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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S74hindered by inability to collect sufﬁcient synovial ﬂuid via joint aspi-
ration. Lavage and ﬂuid wicking can acquire synovial ﬂuid samples in
small animals; however, both techniques are primarily used following
animal euthanasia, making longitudinal OA biomarker analysis practi-
cally impossible in a small animal model.
Our group has developed a magnetic nanoparticle-based technology to
collect OA biomarkers from synovial ﬂuid (Figure 1). First, an antibody
against an OA biomarker is conjugated to the surface of magnetic par-
ticles. Antibody-conjugated particles are used to bind biomarkers in
synovial ﬂuid. Then, a magnetic probe is used to collect a percentage of
the particle-biomarker conjugate from synovial ﬂuid. Biomarker is
released from particles using heat, then particles are released from the
probe using sonication and a magnetic plate. Using a biomarker col-
lected per particle ratio, the amount of biomarker in synovial ﬂuid can
be estimated. The purpose of this study is to assess the sensitivity of
magnetic collection relative to ELISAs conducted on small volume
synovial ﬂuid samples.
Methods: Antibodies against a widely-investigated OA biomarker, C-
telopeptide of type II collagen (CTXII, Immunodiagnostic Systems),
were conjugated to 1-2 mm diameter polystyrene particles containing
10-20 nm diameter superparamagnetic iron oxide nanoparticles
(SPIONS) in the particle core (10% SPIONS by volume). The effect of
synovial ﬂuid viscosity on the magnetic collection technique was
investigated by artiﬁcially degenerating synovial ﬂuid with hyalur-
onidase (0.01 mg/ml for 4.5 hr at room temperature). In particular, 1
billion particles with approximately 400 antibody molecules per par-
ticle were mixed with 400 mL of hyaluronidase-treated or untreated
bovine synovial ﬂuid. To investigate the antibody-CTXII binding kinet-
ics, 50 mL aliquots were acquired for analysis at approximately 1, 2.5, 5,
10, 20, and 40 min. In addition, magnetic particles with approximately
800 antibody molecules per particle were mixed with either hyalur-
onidase-treated or untreated bovine synovial ﬂuid (SF), subjected to
constant gentle mixing for 1 h, then divided into 25 mL samples (97
million particles per sample). In these samples, magnetic needles were
inserted for varying time intervals and the amount of collected particles
was determined by ﬂuorescence.
Results: Synovial ﬂuid viscosity had minor only effects on antibody-
biomarker binding kinetics (Figure 2), indicating the ratio of biomarker
to antibody (or biomarker per particle) could be used to estimate the
initial biomarker amount in a sample as long as magnetic collectionwas
conducted after a dynamic equilibrium was been established. Synovial
ﬂuid viscosity did have marked effects on the collection efﬁciency of
magnetic particles in synovial ﬂuid (Figure 3). However, since magnetic
collection occurred only after the antibody and biomarker reached a
dynamic binding equilibrium, the ratio of biomarker to antibody was
able to estimate the initial concentration of CTXII in a synovial ﬂuid
sample with similar precious to an ELISA conducted on an aliquot of the
same synovial ﬂuid sample (Figure 4).
Conclusions: In this work, critical variables for magnetic collection of
CTXII are described, thereby demonstrating the potential to magneti-
cally collect OA biomarkers in synovial ﬂuid volumes similar to that of a
rat knee. Future work will focus on demonstrating the technique in an
intact rat knee, where joint geometry is far more complex than the
present in vitro studies. Nonetheless, these data demonstrate an in vitro
proof-of-concept for magnetic collection of OA biomarkers.117
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Purpose: Intermittent knee pain is a prevalent complaint in themiddle-
aged population but its signiﬁcance is poorly understood in the absence
of deﬁnitive structural changes. Increased levels of cartilage oligomeric
matrix protein (COMP), a potential prognostic biomarker in early knee
OA, have been associated with risk of incident radiographic knee OA. In
this study, we looked at the cross-sectional association of serum COMP
levels and self-reported knee pain in middle-aged UK females.
Methods: We looked at 724 subjects from the Chingford Cohort Lon-
gitudinal Study who had serum levels of COMP measured at year 2 and
3, and data on self-reported knee pain at year 3. Knee pain was deﬁned
as ‘any knee pain’ if it was present on any number of days in the pre-
ceding month in either knee and ‘pain on most days’ if it was present in
either knee on most days in the preceding month. COMP levels were
categorised into quintiles. A logistic regression model was utilised to
investigate associations between the presence of the knee pain at year 3
and serum COMP levels.
Results: Mean age was 55 years (SD þ/- 5.9; Range 46-68), Mean BMI
was 25.3 (SD þ/- 4; Range 17-47). 205 out of 724 subjects reported ‘any
knee pain’ in the last month, and 80 reported ’pain on most days’ of the
preceding month. The highest COMP quintile (levels above 12.63 U/L),
compared to the lowest, was signiﬁcantly associated with ‘any knee
pain’ in the last month (OR 1.92, 95% CI 1.09 – 3.23). This association
remained signiﬁcant after adjusting for age and vitamin D levels (OR
1.89, 95% CI 1.14 – 3.27), but not after adjustment for BMI (OR 0.7, 95%CI
0.3 – 1.52).
Conclusions: Higher levels of serum COMP are associated with ‘any
knee pain’, but not with reporting knee ‘pain on most days’ in the
preceding month. High COMP levels are associated with intra-articular
joint changes within synovium, cartilage and ligaments. Considering
that inﬂamed synovium is a signiﬁcant pain generator, episodic knee
pain associated with high COMP levels may reﬂect low-grade synovial
inﬂammation.
